Avulux
Charles Posternack is the President & Co-Founder at Avulux. He also serves as the President & CEO at Promise Healthcare, Inc., where he holds the title of Chief Medical Officer. Prior to these roles, he worked as the Managing Director at CHOP Investments, specializing in real estate financing and development. Charles has also held prominent positions such as Chief Medical Officer at Boca Raton Regional Hospital and Chairman of the Board at PFO Global Inc. He graduated from McGill University with a Doctor of Medicine (MD) degree specializing in Gastroenterology.
This person is not in any teams
Avulux
Nearly 2 of every 10 patients an Optometrist sees each day is living with a debilitating disorder called migraine. Even more are living with light sensitivity. Avulux manufactures Avulux Migraine & Light Sensitivity Lenses – a new generation of precision optical filter. Unlike other “migraine” or “neurological” lenses, Avulux Migraine & Light Sensitivity Lenses are clinically proven to help people living with migraine. In fact, Avulux has commissioned two independent studies that demonstrate the superior efficacy of our patented light filtering technology. Avulux Migraine & Light Sensitivity Lenses precisely filter up to 97% of harmful blue, red and amber light while allowing soothing green light through. Actively supporting people living with migraine and light sensitivity is central to everything we do – it’s in our DNA. We are inspired by their stories and motivated by their courage. By delivering clinically-proven, best-in-class therapeutic lens technology, our ambition is to help them reclaim life on their terms. Optometrists in the U.S., Canada, Australia, and New Zealand, can learn about becoming an Avulux Authorized Provider by visiting https://ecp.avulux.com.